$3.96
0.082.06%
At close: -
$3.88
-0.08-2.02%
After Hours: Apr 22, 4:00 PM EDT
Comments
Loading...
DiaMedica Therapeutics Stock Price, Quotes and Forecasts
DMACNASDAQ
DiaMedica Therapeutics (DMAC) Forecast
NewsEarningsDiaMedica Therapeutics (DMAC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
DiaMedica Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DMAC | Benzinga
Explore DiaMedica Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DMAC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy DiaMedica Therapeutics (DMAC) stock?
You can purchase shares of DiaMedica Therapeutics (NASDAQ:DMAC) through any online brokerage.
Who are DiaMedica Therapeutics (DMAC) competitors?
There are no as such competitors for DiaMedica Therapeutics.
What is the forecast, or price target, for DiaMedica Therapeutics (DMAC) stock?
DiaMedica Therapeutics has a consensus price target of $8.00.
What is the current price for DiaMedica Therapeutics (DMAC)?
The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $3.96 last updated April 23, 2025 at 4:00 PM EDT.
Does DiaMedica Therapeutics (DMAC) pay a dividend?
There are no upcoming dividends for DiaMedica Therapeutics.
When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?
DiaMedica Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is DiaMedica Therapeutics (DMAC) going to split?
There is no upcoming split for DiaMedica Therapeutics.
What sector and industry does DiaMedica Therapeutics (DMAC) operate in?
DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
